Skip to search formSkip to main contentSkip to account menu

ImmunoCyt

A combination of 3 fluorescent-tagged monoclonal antibodies. Recently licensed for screening of bladder cancer recurrence by urine test.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Bladder Cancer Screening in Aluminum Smelter Workers
Objective: To present results of a bladder cancer screening program conducted in 18 aluminum smelters in the United States from… 
2010
2010
ImmunoCyt and cytokeratin 20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer: a prospective study.
OBJECTIVE To determine whether ImmunoCyt (uCyt+) immunofluorescence and cytokeratin 20 (CK20) immunocytochemistry add additional… 
Highly Cited
2009
Highly Cited
2009
Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma
ImmunoCyt (uCyt) and UroVysion are ancillary studies that may aid in the detection of urothelial carcinoma in urine specimens. We… 
Review
2009
Review
2009
Critical review of biomarkers for the early detection and surveillance of bladder cancer
Review
2008
Review
2008
Long-term outcome of home dipstick testing for hematuria
The most common symptom of bladder cancer (BC) is hematuria and microhematuria will occur in virtually all patients with BC if… 
Review
2008
Review
2008
Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
Bladder cancer has a very high frequency of recurrence and therefore requires lifelong surveillance, traditionally consisting of… 
Review
2005
Review
2005
Urine markers for bladder cancer surveillance: a systematic review.
2004
2004
How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer.
A handful of cancer biomarkers are currently used routinely for population screening, disease diagnosis, prognosis, monitoring of… 
2003
2003
Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
The ImmunoCyt assay (Diagnocure Inc., Québec, Canada) is a new immunocytological fluorescence test for identifying two different… 
Highly Cited
2001
Highly Cited
2001
ImmunoCytTM a Useful Method in the follow-up Protocol for Patients with Urinary Bladder Carcinoma
Objective: To evaluate the ImmunoCytTM test - a urine-bound test for the detection of malignant transitional cells. Patients and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)